Register
Full name*
Email Address*
Are you a member of IChemE?*
Marketing Permission
^If you supply us with personal details through this website, you consent to us maintaining, recording, holding and using such personal data in accordance with IChemE’s privacy policy. For us to process and administer your booking, your details and those of the delegate(s) (if different) will be added to our database. New delegates being added to our database for the first time will shortly receive an email with further information about how they can manage their data, in accordance with the Data Protection Regulations 2018.
✓ Yes, I consent to receiving emails*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
About This Webinar
The Joint Chemical Engineering Committee (JCEC) Western Australia invites you to join them for this presentation on the development and manufacturing of vaccines in Australia.

It has been widely reported that Australia can end lockdowns and start to reopen to the world once 80 per cent of the population is vaccinated – and we may be able to get there by the end of the year, according to a new Grattan Institute report.

The WA JCEC has invited a group of experts to tell us more about COVID vaccines in Australia, including how they are developed and how we can more effectively deploy them in the fight against COVID19.
J
Jeremy McManus
Joint Chemical Engineering Committee, Western Australia
1626047822-27a2d8b9e5abe3f4
Fiona O'Connor
Institution of Chemical Engineers (IChemE)
1629676180-e2de5e637d72c6fb
Xiaoxiao Jia
Fellow in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
Xiaoxiao Jia is currently a post-doc research fellow in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne. She acquired her master degree in Bioengineering from Institute of Microbiology, Chinese Academy of Sciences and joined Peter Doherty Institute for Infection and Immunity, University of Melbourne in 2017 to pursue PhD in Immunology. She completed her PhD in 2021 and her research focuses on host immune responses during severe influenza diseases, and is involved in projects to dissect human immunity towards SARS-CoV-2 infection, as well as immune protection post vaccinations in various cohorts including pregnant women, immune deficient patients and Indigenous.
1629676657-d6f25d71aa161c56
Dr Danzi Song
Pharmaceutical Formulation Scientist, CSL Behring
Dr. Danzi Song is a pharmaceutical formulation scientist currently working at CSL Behring, a global biotech leader for the supply of life saving plasma derived products. CSL played a significant role during the COVID-19 pandemic as the only local vaccine manufacturer in Australia. Danzi was involved in supporting one of the vaccine programs.

She completed her PhD in Chemical and Biomolecular Engineering from the University of Melbourne in 2018. Her research focus was nanomedicine and targeted drug delivery. On the side, Danzi is passionate about fostering entrepreneurship in biotech sector. She sits at the advisory board of Australia China Association of Scientists and Entrepreneurs and worked as an investment analyst for a venture capital company.
D
Dr Frank Wang M.D
Dr Frank Wang M.D. works as an emergency doctor at Monash Health, a tertiary health network located at the eastern suburbs of Melbourne. He graduated from Melbourne Medical School, University of Melbourne in 2017. He is also the cofounder of a company named Moyi Health tech. Dr Wang has a special interest in health promotion and gave several presentations on topics such as palliative care, osteoporosis, hepatitis, COVID vaccine to the general community in the past few years.
G
Guoping Hu
Joint Chemical Engineering Committee (JCEC) Western Australia
Research Associate at The University of Western Australia
F
Fiona O'Connor
Market Development and Sales Executive - Australasia
Institution of Chemical Engineers (IChemE)
Share
COPY
Powered by BigMarker